Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Gains from Sales and Divestitures (2021)

Historic Gains from Sales and Divestitures for HeartSciences (HSCS) over the last 1 years, with Q2 2021 value amounting to $1663.0.

  • HeartSciences' Gains from Sales and Divestitures changed N/A to $1663.0 in Q2 2021 from the same period last year, while for Apr 2021 it was $1663.0, marking a year-over-year change of. This contributed to the annual value of $1663.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that HeartSciences reported Gains from Sales and Divestitures of $1663.0 as of Q2 2021.
  • Over the past 5 years, HeartSciences' Gains from Sales and Divestitures peaked at $1663.0 during Q2 2021, and registered a low of $1663.0 during Q2 2021.